about
A positive feedback loop of ER-α36/EGFR promotes malignant growth of ER-negative breast cancer cellsMethylation-dependent silencing of CST6 in primary human breast tumors and metastatic lesionsEstablishment of the epithelial-specific transcriptome of normal and malignant human breast cells based on MPSS and array expression dataBasal cytokeratins and their relationship to the cellular origin and functional classification of breast cancermiRNAs as potential biomarkers in early breast cancer detection following mammographyCircadian disruption and breast cancer: an epigenetic link?BRCA genetic screening in Middle Eastern and North African: mutational spectrum and founder BRCA1 mutation (c.798_799delTT) in North AfricanUnraveling the microenvironmental influences on the normal mammary gland and breast cancerRadiation-induced molecular changes in rat mammary tissue: possible implications for radiation-induced carcinogenesisAtypical epithelial hyperplasia of the breast: state of the art.The role of ultrasonographic findings to predict molecular subtype, histologic grade, and hormone receptor status of breast cancer.Wnt signaling in triple negative breast cancer is associated with metastasisCombined contrast-enhanced magnetic resonance and diffusion-weighted imaging reading adapted to the "Breast Imaging Reporting and Data System" for multiparametric 3-T imaging of breast lesions.Mining genome sequencing data to identify the genomic features linked to breast cancer histopathology.Cell cycle related proteins in hyperplasia of usual type in breast specimens of patients with and without breast cancer.Nectin-4 is a new histological and serological tumor associated marker for breast cancer.Genomic alterations in sporadic synchronous primary breast cancer using array and metaphase comparative genomic hybridization.Assessing the significance of conserved genomic aberrations using high resolution genomic microarrays.The assessment of angiogenesis and fibroblastic stromagenesis in hyperplastic and pre-invasive breast lesions.Low expression of a few genes indicates good prognosis in estrogen receptor positive breast cancer.High prevalence of PIK3CA/AKT pathway mutations in papillary neoplasms of the breast.Malignant precursor cells pre-exist in human breast DCIS and require autophagy for survivalEndoplasmic reticulum calcium pumps and cancer cell differentiation.Genomic distance entrained clustering and regression modelling highlights interacting genomic regions contributing to proliferation in breast cancerAberrant PTPRO methylation in tumor tissues as a potential biomarker that predicts clinical outcomes in breast cancer patients.Gene expression in histologically normal epithelium from breast cancer patients and from cancer-free prophylactic mastectomy patients shares a similar profile.Claudin 1 in breast tumorigenesis: revelation of a possible novel "claudin high" subset of breast cancers.Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density.Mechanisms of epigenetic silencing of the Rassf1a gene during estrogen-induced breast carcinogenesis in ACI rats.Rates of atypical ductal hyperplasia have declined with less use of postmenopausal hormone treatment: findings from the Breast Cancer Surveillance Consortium.The functional interaction between Acyl-CoA synthetase 4, 5-lipooxygenase and cyclooxygenase-2 controls tumor growth: a novel therapeutic target.Luminal A and luminal B (HER2 negative) subtypes of breast cancer consist of a mixture of tumors with different genotype.Absence of microsatellite instability in mucinous carcinomas of the breast.Comprehensive copy number profiles of breast cancer cell model genomes.Unlocking pathology archives for molecular genetic studies: a reliable method to generate probes for chromogenic and fluorescent in situ hybridization.Lattice-based model of ductal carcinoma in situ suggests rules for breast cancer progression to an invasive stateThe molecular pathology of breast cancer progression.Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines.Effects of celecoxib and ly117018 combination on human breast cancer cells in vitro.Dual-color fluorescence in situ hybridization reveals an association of chromosome 8q22 but not 8p21 imbalance with high grade invasive breast carcinoma.
P2860
Q24302285-AD37BE5C-A9A4-4BF2-A23D-DAD018A48042Q24648542-D87DCAD2-355A-4161-A7D7-102F970822FDQ24684071-65101912-D44E-4959-9879-10935E9C0971Q24810751-656E55D8-8F9B-40CE-BD85-C8620F3E7EBFQ26773094-6F314403-D2EF-4759-A745-8E1C13535276Q26798258-0E209EC2-09E0-482D-8E91-54F02B8FE499Q27002334-42059B04-87A7-4D46-965C-306D4118508FQ28473677-EE19EC80-5996-4712-A985-1AF2E5217293Q28577758-CE750403-576B-4AD8-8638-20379FB239B3Q30249199-A0FE161C-E511-4501-95FA-7AD48F1DEF34Q30399282-A37CBDE9-F48A-4C28-A31F-50107C645323Q30597238-5A68D0A4-1AEB-4803-8B4F-00C40F6189F0Q30600800-A8A5FECA-3782-4C72-AC36-B7825DFCDDFCQ30786619-67DE76BA-D8BA-4D55-9DBD-4090E4922A62Q30820696-52A31809-553B-4963-9425-CA6782A16D2AQ33283461-BE618736-73EE-40CC-A8C5-EAADFE229508Q33289495-64A08E7B-57D4-49CE-A5CD-000D304DD037Q33295223-386B24A1-8610-46D0-B424-4A67B122F84CQ33326756-89CC3ADB-EFEE-47A8-BCC2-D70DC05BF0B1Q33484404-7FF52A49-DE4E-4974-A918-13DAFCEBDF44Q33515565-C82B6EA9-EAFC-4B81-AA97-1D64F9BAF10DQ33565313-3B7F4146-7E5F-4B71-AB07-EE1E7DF7EE40Q33649613-ECE11722-9C6D-4CAB-9EA0-401955B30571Q33687781-BB2C59C2-E5DA-48D9-A618-E52DD99BEBB7Q33775528-6785310B-A51B-4F94-B32B-B10B288619A5Q33794872-AD674629-2D39-400C-9C50-BF50242A6BDEQ33856016-0ED60065-3939-4506-AC88-A086D8ED366CQ33926477-059F9599-CDD9-4F94-AF1D-5F4C666F3186Q33974223-28DAF733-132C-44BF-87CA-F128D2F0D164Q34062503-BA49D534-6574-4348-A6EC-1FF3F6BC2953Q34342416-D64AF742-4537-4147-A3BD-889EDF12DF54Q34351294-A4E6FB37-77A6-474B-8479-117F77C9F17DQ34467216-BE18446E-7F0C-4F1A-98E6-2406E2BE3B05Q34480698-792E0564-F737-4D36-9A7D-B4C8DBA450F0Q34489686-B0A2CCDE-7CA1-4287-9A18-2334EC81F270Q34632827-88BEB6BB-ED9E-4D87-AB03-77DECE784972Q34752938-94D82AA5-AC95-49B5-82E5-FFC7CF71742CQ34760593-64C8018F-8DC3-4B48-B442-690120F3C134Q34908885-CB9043AA-74C7-4C95-89F6-4B900EEE1726Q34923557-41E0B869-22B4-45B7-9B68-A3EAE991DC68
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Molecular evolution of breast cancer.
@ast
Molecular evolution of breast cancer.
@en
type
label
Molecular evolution of breast cancer.
@ast
Molecular evolution of breast cancer.
@en
prefLabel
Molecular evolution of breast cancer.
@ast
Molecular evolution of breast cancer.
@en
P2860
P50
P356
P1476
Molecular evolution of breast cancer.
@en
P2093
Theodora Gale
P2860
P304
P356
10.1002/PATH.1691
P577
2005-01-01T00:00:00Z